Introduction
Gastric cancer is one of the major cancers in the world and has caused serious damages to human health. Based on the GLOBOCAN 2008 estimates, about 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred (de Martel et al., 2012) . In addition to the H. pylori strain, and various environmental factors which are major risk factors, genetic background also plays an important role (Companioni et al., 2013; Lee and Derakhshan, 2013) . The matrix metalloproteinase RESEARCH ARTICLE
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Teng-Fei Yang, Lin Guo, Qiang Wang* members of the MMP family. Four polymorphisms in the promoter region of these MMPs, which are MMP1-1607 1G/2G, MMP-2 1306 C>T, MMP7-181 A>G, and MMP9-1562 C>T, have been reported to be functional and may contribute to genetic susceptibility to cancers (McColgan and Sharma, 2009; Peng et al., 2010) . Many studies have showed that SNP of MMPs genes may be associated with gastric cancer risk. However, the associations between these polymorphisms and gastric risk remain inconclusive due to conflicting results from different case-control studies. Therefore, we performed a meta-analysis to clarify clinical impact of MMP gene polymorphisms in gastric cancer.
Materials and Methods

Search strategy
The literature search was aimed to find all relevant studies that examined the association of MMP-1, MMP-2, MMP-7,and MMP-9 polymorphisms with gastric cancer following electronic databases: the Med-line, Embase, Science Citation Index, and PubMed databases between August 1992 and June 2013. The following medical subject heading terms were used: "matrix metalloproteinase", "gastric cancer", "MMP" ,and"polymorphisms". The "related articles" function was used to broaden the search, and all abstracts, studies, and citations scanned were reviewed. A manual search of the bibliographies of relevant journals was also carried out to identify trials for possible inclusion.
Selections of studies
The inclusion criteria for the present meta-analysis were as follows: (1). patients included in the study were gastric cancer ; (2). they used an unrelated case-control design; (3). availability of genotypes or allelic frequencies; and (4). they applied a useful genotyping method and presented sufficient data to calculate the odds ratio (OR). with a confidence interval (CI). and a P-value.
Abstracts, letters, editorials and expert opinions, reviews without original data, case reports, and studies lacking control groups were excluded. The following studies or data were also excluded: 1). the outcomes and parameters of patients were not clearly reported; 2). it was impossible to extract the appropriate data from the published results; and 3). there was overlap between authors or centers in the published literature.
Data extraction
Details extracted from each report included the first author, published year, ethnicity of study population (Asian or European), numbers of case and controls, genotype distribution, genotyping methods, allele, etc. All data were extracted and registered into two databases independently by two reviewers (TF Yang and L Guo). to avoid bias in the data extraction process. Any disagreement between these two investigators was resolved by consensus or by consultation with additional reviewers (Wang Q).
Statistical analysis
First, we tested Hardy-Weinberg equilibrium (HWE). by comparing the expected and observed genotype frequencies of the control group using the Pearson chisquare test for goodness of fit. The association between the MMP polymorphisms and risk of gastric cancer was assessed by OR and 95% CI. Heterogeneity among the studies was assessed by the chi-square test. P value<0.05 was considered to be heterogeneous obviously. At the same time, I 2 also was used to assess the heterogeneous. We considered heterogeneity to be present if the I 2 statistic was >50%. P < 0.05 was considered significant. Heterogeneity was to be explored by subgroup analysis or a random-effects model. Publication bias was quantitatively evaluated using funnel plots. The pooled ORs were performed on the dominant (Xx + xx versus XX), recessive model (xx versus XX + Xx), and allelic contrast (x versus X). respectively (X represented major allele, x represented minor allele). All analyses were conducted using STATA 12.0 (STATA Corporation, College Station, Texas), using two sided P values, and all tests were two sided.
Results
Selected studies
According to our criteria, there were 14 studies including 2980 cases and 5166 controls, gastric cancer was confirmed by histological or pathogenic method in each study. Genotype counts of the analyzed polymorphisms of studies included in the meta-analysis were showed in Table 1 . The frequencies of age and sex were matched between cases and controls in each study. No studied had a deviation from Hardy-Weinberg equilibrium in controls at a statistical significance level of 0.01 (Table 1) . The reasons for exclusion were described in Figure 1 . Overall, as shown in Table 2 , we observed that the MMP-7 (-181A>G). polymorphism increased the gastric cancer risk in recessive model GG vs. AA/AG, OR=1.768, 95% CI =1.153-2.712). when all the eligible studies were pooled into the meta-analysis (Table 2 ). In the subgroup analysis, we found that the MMP-7 (-181A>G). polymorphism in Asian elevates gastric cancer risk in all the three models (GG vs. AA, OR =2.016, 95% CI=1.131-3.595; GG/AG vs. AA, OR=1.550, 95% CI=1.194-2.012; GG vs. AA/AG, OR=2.130, 95% CI=1.297-3.499) ( Figure 3) .
Figure 1. Flow Chart of Studies Identified, Included and Excluded
MMP2 −1306 C>T There were eight studies for MMP2 −1306 C>T when analyzed on the overall and subgroup analysis, there was no association between the risk of gastric cancer and this polymorphism under the dominant and recessive models (Table 2) . (dominant, OR=0.776, 95%CI 0.556-1.077, p=0.0001, I 2 =80.7%; recessive, OR=0.851, 95%CI 0.534-1.356, p=0.138, I 2 =36.4%). (Figure 2) . MMP-9 − 1562 C>T and MMP1-1607 1G/2G In overall comparison, there was no association between these two polymorphisms and risk of gastric cancer under the dominant and recessive models ( Table 2) . Because of the limited data, we did not analyze the data based on the ethnicity study population for these two polymorphisms.
Discussion
This meta-analysis of 17 studies involving 7983 cases and 7382 controls was performed to investigate the relationship between four polymorphisms in MMP gene and gastric cancer risk. We found that MMP7 (−181). polymorphism increased this risk. In contrast, no significant difference was found in any genotype of MMP-1, MMP-2 or MMP-9.
The associations between SNP of MMPs genes and other cancers have been investigated by many studies. A meta-analysis based on 17 studies published case-control studies, including 7983 cases and 7382 controls, found that MMP1-1607 1G/2G polymorphism may contribute to lung cancer susceptibility, but no significant difference was found in any genotype of MMP2-735 C/T, MMP2-1306 C/T or MMP9-1562 C/T (Hu et al., 2013) . Another metaanalysis based on 9 published case-control studies, found that MMP2-1306 C/T increased the risk of breast cancer. However, there was no association with polymorphisms of MMP1-1607 1G/2G, MMP3-1171 5A/6A and MMP9-1562 C/T (Zhou et al., 2011) .
In some research, the polymorphism of MMP1 promoter could increase the risk of digestive cancers significantly and indicating its role in the development of many carcinomas was stimulative (Li et al., 2013) . It may be contributed to 2G allele creates an E26 (Ets). transcription factor binding site and increases transcription capacity (Rutter et al., 1998) . However, our meta-analysis indicated no significant association between the MMP1 polymorphism and gastric cancer risk.
Seveal studies have evaluated associations for the polymorphisms of MMP7 (− 181). with risk of gastric cancer. For MMP7 (− 181), individuals with -181G allele had a higher risk of gastric cancer under the recessive model, no association was found under the dominant model. Individuals with excess MMP-7 activity by harboring the -181G allele may predispose to malignant transformation through the 'sheddase' activity of MMP-7 protein, via recently described substrates such as tumor necrosis factor-α, E-cadherin and Fas ligand. These substrates have been known to play important roles in signal transduction, cell-cell adhesion and apoptosisthis (Carneiro et al., 2004; Fingleton et al., 2001; Noe et al., 2001) . Subgroup analyses by ethnicity showed there was no association between MMP7 (−181). polymorphism and gastric cancer risk in European under all genetic models but MMP7 (−181). polymorphism was associated with increased risk of gastric cancer in Asian under the three model.
Several studies have reported that MMP2 and MMP9 are highly expressed in tumor tissues compared to normal tissues, polymorphisms of MMP2 (−1306), and MMP9 (−1562). play significant roles in cancer development. Previous studies showed that C allele of MMP2 (−1306). had higher promoter activity than T allele, (Price et al., 2001) . and C allele of MMP9 (−1562). had lower promoter activity than T allele (Zhang et al., 1999) . However, our meta-analysis had included several literatures, the pooled OR results demonstrated that there was no association with risk of gastric cancer for these two polymorphisms. The two genetic variants were not a major risk factor for the development of gastric cancer. Whether environment factors participated in pathogenesis of gastric cancer for these two polymorphisms should be clarified in further studies.
Different MMP polymorphisms result in different associations with gastric cancer risk. Several reasons might explain this problem. First, population for each study came from different regions and ethnicity, different genetic backgrounds and environmental factors could influence the result. Second, the molecular mechanism of the relation ship of SNP of MMPs genes and gastric cancer risk were different.
There are also some shortcomings needed to be discussed. Firstly, the inclusion of few studies with relatively small sample size and poor validation was a main limitation of the meta-analysis. Secondly, lack of available information prevented a more precise evalation with adjusted ORs by age, gender, smoking status and different histological types of gastric cancer, etc. Although it is difficult for us to analyze the interaction between gene and environment, it is necessary to evaluate the roles of some special environmental factors and life styles such as diet, alcohol consumption, and smoking status in developing gastric cancer. Thirdly, while all of these studies were reported on European and Asians, more studies are required in other population types such as Africans.
In conclusion, this meta-analysis suggested that MMP7-181 A>G polymorphism may contribute to gastric cancer susceptibility. Future studies are needed to confirm this association and to focus on the possible mechanisms.
